Sanofi and GSK Lead $40 Billion Rout as Zantac Worries Mount

(Bloomberg) — Sanofi, GSK Plc and Haleon Plc extended their declines and have lost a combined $40 billion in market value since Tuesday’s close amid mounting concerns about litigations around recalled heartburn drug Zantac. Sanofi fell about 13% on Thursday, taking its two-day decline to 20%, the steepest drop ever over that timeframe. GSK slid … Read more

Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vacc

Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine Primary vaccination with Beta-containing vaccine candidate delivers 64.7% efficacy against symptomatic infection in adults, and 75.1% efficacy in participants previously infected with COVID-19 Against Omicron, sequencing analysis performed to date shows 72% efficacy in all adults and 93.2% in seropositives Favorable … Read more

Sanofi says COVID-19 vaccine candidate yields positive trial data

PARIS (Reuters) – Sanofi’s COVID-19 vaccine candidate, which is modelled on the virus’s Beta antigen, delivered 72% efficacy in adults against the Omicron strain, the French drugmaker said on Friday, citing data gathered in a study. “Sanofi-GSK’s vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron … Read more